Vijaya Diagnostic Centre Ltd.

NSE: VIJAYA · Healthcare

₹1,468.60+2.15%06 Nov 2026

Ask the data

Instant answers about Vijaya Diagnostic Centre Ltd. — computed from its filings, no language model

Market cap₹15,126 cr

Current price₹1,468.60

High / Low₹1,571 / ₹861

P/E74.3

P/B14.31

Book value₹102.7

ROE19.3%

ROCE29.6%

Debt / equity0.00

Dividend yield0.14%

EPS (TTM)₹19.78

Face value₹1

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY22	FY23	FY24	FY26
Revenue	462.4	459.2	547.8	814.2
EBITDA	203.7	182.0	220.9	336.9
Operating margin	44.1%	39.6%	40.3%	41.4%
Interest	16.4	20.9	24.0	33.2
Depreciation	52.7	61.7	57.0	91.8
Profit before tax	147.4	113.5	158.7	232.7
Tax	36.7	28.3	39.0	59.7
Net profit	109.7	84.6	118.8	173.0
EPS ₹	10.76	8.29	11.62	16.81
Operating cash flow	158.0	164.6	183.3	270.6
Capex	122.3	124.8	88.0	182.7
Dividend paid	0.0	10.2	10.2	20.5
Total assets	713.5	853.4	982.8	1,507.0
Equity	468.2	544.7	657.2	957.1

Quarterly performance

last 19 quarters · ₹ crore

showing latest 8 of 19 periods

	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	112.7	110.8	116.2	104.4	120.8	121.0	121.0	138.9	132.7	155.2	156.2	182.9	169.0	188.1	201.6	205.2	219.4	231.0	255.4
Operating profit	51.1	47.8	47.9	39.9	48.7	49.1	48.1	57.4	52.3	63.1	61.2	76.0	67.1	73.5	81.8	86.0	95.5	98.5	112.8
Operating margin	45.4%	43.2%	41.2%	38.2%	40.4%	40.6%	39.8%	41.3%	39.4%	40.7%	39.2%	41.5%	39.7%	39.1%	40.6%	41.9%	43.5%	42.7%	44.1%
Other income	3.1	3.2	3.2	2.8	3.3	4.5	5.7	6.8	5.1	3.2	3.6	4.5	4.7	7.0	6.2	5.1	2.4	8.5	5.0
Interest	3.9	4.2	4.3	4.8	4.9	5.8	5.9	5.8	6.1	6.2	6.3	6.5	6.8	7.5	7.8	8.6	9.3	11.0	11.4
Depreciation	12.5	13.0	15.3	14.2	15.9	11.4	12.5	13.7	14.5	16.3	16.6	16.8	18.3	20.9	22.3	24.3	24.3	25.1	26.9
Profit before tax	37.9	33.9	31.4	23.7	31.3	36.5	35.5	44.6	34.8	43.9	41.9	57.2	46.7	52.2	58.0	58.2	64.3	70.9	79.4
Tax	9.9	8.4	7.5	6.2	7.8	8.8	9.1	11.0	8.8	10.2	10.4	15.1	11.4	13.6	14.7	15.1	16.3	17.8	19.9
Net profit	27.7	25.3	23.7	17.4	23.3	27.5	26.2	33.3	25.9	33.5	31.4	41.9	35.2	38.3	43.3	43.2	47.9	53.1	59.5
EPS ₹	2.72	2.48	2.33	1.71	2.29	2.69	2.57	3.26	2.53	3.27	3.06	4.09	3.42	3.76	4.21	4.20	4.66	5.16	5.78
Revenue YoY	—	—	—	—	7.1%	4.1%	16.0%	15.0%	—	28.3%	29.1%	31.8%	27.3%	20.4%	10.2%	21.4%	—	22.8%	26.7%
Profit YoY	—	—	—	—	-15.8%	15.9%	50.1%	42.8%	—	21.7%	19.7%	25.9%	36.0%	22.3%	3.2%	22.8%	—	38.5%	37.4%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 10 periods

	JUN '22	SEP '22	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '26	JUN '26	SEP '26
ROE	20.1%	17.9%	18.9%	18.1%	18.9%	18.3%	19.6%	18.0%	19.6%	19.3%
ROCE	30.7%	27.7%	29.3%	27.8%	28.8%	28.0%	29.7%	27.8%	30.1%	29.6%
Net margin	21.2%	19.9%	22.0%	21.7%	21.3%	21.1%	21.4%	21.2%	21.9%	22.4%
EBITDA margin	42.1%	40.8%	40.3%	40.3%	40.1%	40.3%	40.3%	41.4%	42.2%	43.1%
Debt / equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest coverage	8.36	7.62	7.42	7.62	7.78	8.11	8.37	8.00	7.84	7.77
Asset turnover	0.62	0.57	0.55	0.56	0.59	0.56	0.59	0.54	0.57	0.53

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 10 periods

	MAR '21‡	MAR '22‡	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	SEP '25	MAR '26	SEP '26
Share capital	4.5	10.2	10.2	10.2	10.2	10.2	10.3	10.3	10.3	10.3
Other equity / reserves	354.5	458.0	490.1	534.5	586.5	647.0	714.6	854.8	946.9	1,047.0
Total equity	359.0	468.2	500.3	544.7	596.7	657.2	724.9	865.1	957.1	1,057.3
Borrowings	4.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Current liabilities	44.3	66.1	73.3	66.2	78.7	72.9	116.3	160.3	123.9	160.9
Non-current liabilities	137.7	177.8	224.3	240.6	248.3	250.0	281.1	365.3	426.0	515.2
Total assets	541.2	713.5	799.5	853.4	926.1	982.8	1,125.3	1,390.7	1,507.0	1,733.3
Property, plant & equipment	135.8	196.6	479.1	294.0	560.8	602.2	663.6	843.4	929.6	1,044.6
Capital work-in-progress	8.2	34.1	8.6	249.4	15.2	8.2	17.6	45.3	34.3	33.0
Investments	—	—	84.5	139.0	195.2	109.2	159.6	228.7	228.4	304.1
Inventories	2.6	4.3	4.5	2.0	3.7	5.2	6.6	3.6	4.9	8.3
Receivables	6.7	9.8	8.6	9.5	10.3	16.2	12.8	11.9	20.9	17.9
Cash & equivalents	6.7	11.1	19.0	24.2	23.2	22.2	14.7	24.2	39.7	10.1

Cash flow

annual · ₹ crore · line = free cash flow

	FY21‡	FY22	FY23	FY24	FY26
Cash from operations	129.6	158.0	164.6	183.3	270.6
Cash from investing	-129.8	-123.1	-109.6	-142.3	-174.2
Cash from financing	-48.8	-30.6	-41.9	-44.5	-69.5
Capex	32.1	122.3	124.8	88.0	182.7
Free cash flow	97.5	35.6	39.8	95.3	87.9
Dividends paid	—	0.0	10.2	10.2	20.5

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,044.6 cr60%

CWIP

₹33.0 cr2%

Investments

₹304.1 cr18%

Inventories

₹8.3 cr0%

Receivables

₹17.9 cr1%

Cash & equivalents

₹10.1 cr1%

Other assets

₹315.4 cr18%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Vijaya Diagnostic Centre Ltd.	15,126	1,468.60	74.3	14.31	19.3%

StoxGud checklist: Bullish setup · 9/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+0.4%

6 months+21.6%

1 year+45.8%

3Y CAGR+35.9%

5Y CAGR+21.1%

10Y CAGR—

50-day avg₹1,460.89

200-day avg₹1,244.07

RSI (14)67

Compare Vijaya Diagnostic Centre Ltd. with

Syngene International vs Vijaya Diagnostic Centre Cohance Lifesciences vs Vijaya Diagnostic Centre Poly Medicure vs Vijaya Diagnostic Centre Vijaya Diagnostic Centre vs NATCO Pharma Vijaya Diagnostic Centre vs Rainbow Childrens Medicare Vijaya Diagnostic Centre vs Concord Biotech

FAQs

What is the share price of Vijaya Diagnostic Centre Ltd.?

Vijaya Diagnostic Centre Ltd. (VIJAYA) closed at ₹1,468.60 on NSE on 06 Nov 2026.

What is the market cap of Vijaya Diagnostic Centre Ltd.?

₹15,126 crore at the latest close.

What is the P/E ratio of Vijaya Diagnostic Centre Ltd.?

74.3, on trailing-twelve-month earnings from its filings.

How fast is Vijaya Diagnostic Centre Ltd. growing?

Vijaya Diagnostic Centre Ltd.: revenue has compounded at 20.8% a year over three years; net profit at 16.4% a year. Latest-quarter revenue is up 26.7% year on year, profit up 37.4%.

How profitable is Vijaya Diagnostic Centre Ltd.?

On a trailing-twelve-month basis return on equity is 19.3%, return on capital employed 29.6%, operating margin 43.1%, net margin 22.4%.

How much debt does Vijaya Diagnostic Centre Ltd. have?

Vijaya Diagnostic Centre Ltd. is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹10 cr (balance sheet of 2026-09-30). Operating profit covers interest 7.8 times.

Financials parsed from Vijaya Diagnostic Centre Ltd.'s own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '21, annual from FY22, balance sheet from Mar '21. * = derived (full year or half year minus earlier quarters). ‡ = balance sheet / cash flow read from the company's published annual report (same basis), for years before the NSE filings carry them; each one checked to add up. Information only, not investment advice.